The therapeutic importance of insulin-like growth factor I (IGF-I) for the treatment of some central nervous system disorders, including premenstrual syndrome (PMS) and Rett syndrome in children is immense (Costales and Kolevzon, 2016). Here, IGF1 is linked to Rett syndrome.